USRM- U.S. STEM CELL, INC. MYOCELL. Currently FDA Approved in phase 2/3.
Buyout possibly looming but being held up by court case. Do your DD.
Another clinic may be opening from a Facebook post by someone in training at us stem cell that lives in New Jersey.
A lot of catalysts that could be coming here. Dilution has seem to be very minimum. Market cap is around 300k. So low! Competition in stem cell is around 1.00 pps. Many strong hands holding USRM. Good day!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.